Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-22T07:06:34.000Z Has data issue: false hasContentIssue false
  • English
  • Français

Rhythmic low-field magnetic stimulation may improve depression by increasing brain-derived neurotrophic factor

Published online by Cambridge University Press:  20 February 2018

Le Xiao ,
Christoph U. Correll ,
Lei Feng ,
Yu-Tao Xiang ,
Yuan Feng ,
Chang-Qing Hu ,
Rena Li  and
Gang Wang
Le Xiao
Affiliation:
The National Clinical Research Center for Mental Disorders and Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China
Christoph U. Correll
Affiliation:
Department of Psychiatry, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, New York, United States
Lei Feng
Affiliation:
The National Clinical Research Center for Mental Disorders and Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China
Yu-Tao Xiang
Affiliation:
Unit of Psychiatry, Faculty of Health Sciences, University of Macau, Macao SAR, China
Yuan Feng
Affiliation:
The National Clinical Research Center for Mental Disorders and Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China
Chang-Qing Hu
Affiliation:
The National Clinical Research Center for Mental Disorders and Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China
Rena Li
Affiliation:
The National Clinical Research Center for Mental Disorders and Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China Beijing Institute for Brain Disorders, Capital Medical University, Beijing, China
Gang Wang*
Affiliation:
The National Clinical Research Center for Mental Disorders and Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China
*
*Address for correspondence: Dr. Gang Wang, Mood Disorders Center, Beijing Anding Hospital, No. 5 Ankang Lane, Deshengmenwai Avenue, Xicheng District, Beijing 100088, China. (Email: [email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

Low-field magnetic stimulation (LFMS) has mood-elevating effect, and the increase of brain-derived neurotrophic factor (BDNF) is associated with antidepressant treatment. We evaluated the effects and association with BDNF of rhythmic LFMS in the treatment of major depressive disorder (MDD).

Methods

A total of 22 MDD patients were randomized to rhythmic alpha stimulation (RAS) or rhythmic delta stimulation (RDS), with 5 sessions per week, lasting for 6 weeks. Outcomes assessments included the 17-item Hamilton Depression Rating Scale (HAMD–17), the Hamilton Anxiety Rating Scale (HAMA), and the Clinical Global Impressions–Severity scale (CGI–S) at baseline and at weeks 1, 2, 3, 4, and 6. Serum BDNF level was measured at baseline and at weeks 2, 4, and 6.

Results

HAMD–17, HAMA, and CGI–S scores were significantly reduced with both RAS and RDS. RAS patients had numerically greater reductions in HAMD–17 scores than RDS patients (8.9 ± 7.4 vs. 6.2 ± 6.2, effect size [ES]=0.40), while RDS patients had greater improvement in HAMA scores (8.2 ± 8.0 vs. 5.3 ± 5.8, ES=0.42). RAS was associated with clinically relevant advantages in response (54.5% vs. 18.2%, number-needed-to-treat [NNT]=3) and remission (36.4% vs. 9.1%, NNT=4). BDNF increased significantly during the 6-week study period (p<0.05), with greater increases in RAS at weeks 4 and 6 (ES=0.66—0.76) and statistical superiority at week 2 (p=0.034, ES=1.23). Baseline BDNF in the 8 responders (24.8±9.0 ng/ml) was lower than in the 14 nonresponders (31.1±7.3 ng/ml, p=0.083, ES=–0.79), and BDNF increased more in responders (8.9±7.8 ng/ml) than in nonresponders (1.8±3.5 ng/ml, p=0.044). The change in BDNF at week 2 was the most strongly predicted response (p=0.016).

Conclusions

Rhythmic LFMS was effective for MDD. BDNF may moderate/mediate the efficacy of LFMS.

Keywords

Major depressive disorderrhythmic magnetic stimulationbrain-derived neurotrophic factormoderatormediator
Type
Original Research
Information
CNS Spectrums , Volume 24 , Issue 3 , June 2019 , pp. 313 - 321
Copyright
© Cambridge University Press 2018 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

This study was funded by the Beijing Municipal Administration of Hospitals, Clinical Medicine Development of Special Funding Support no. ZYLX201403; by the Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support no ZYLX201607; by the Beijing Municipal Administration of Hospitals Incubating Program, Code no. PX2017048; by the National Key Technology Research and Development Program of the Ministry of Science and Technology of China grant no. 2015BAI13B03; and by the Beijing Municipal Administration of Hospitals’ Ascent Plan, Code no. DFL20151801.

References

REFERENCES

1. Rohan, M, Parow, A, Stoll, AL, Demopulos, C, et al. Low-field magnetic stimulation in bipolar depression using an MRI-based stimulator. Am J Psychiatry. 2004; 161(1): 93–98.Google Scholar
2. Rohan, ML, Yamamoto, RT, Ravichandran, CT, et al. Rapid mood-elevating effects of low field magnetic stimulation in depression. Biol Psychiatry. 2014; 76(3): 186–193.Google Scholar
3. Carlezon, WA, Rohan, ML, Mague, SD, et al. Antidepressant-like effects of cranial stimulation within a low-energy magnetic field in rats. Biol Psychiatry. 2005; 57(6): 571–576.Google Scholar
4. Shafi, M, Stern, AP, Pascual-Leone, A. Adding low field magnetic stimulation to noninvasive electro-magnetic neuromodulatory therapies. Biol Psychiatry. 2014; 76(3): 170–171.Google Scholar
5. Leuchter, AF, Cook, IA, Jin, Y, Phillips, B. The relationship between brain oscillatory activity and therapeutic effectiveness of transcranial magnetic stimulation in the treatment of major depressive disorder. Front Hum Neurosci. 2013; 7: 37.Google Scholar
6. Leuchter, AF, Cook, IA, Feifel, D, et al. Efficacy and safety of low-field synchronized transcranial magnetic stimulation (sTMS) for treatment of major depression. Brain Stimul. 2015; 8(4): 787–794.Google Scholar
7. Kammer, T, Spitzer, M. Brain stimulation in psychiatry: methods and magnets, patients and parameters. Curr Opin Psychiatry. 2012; 25(6): 535–t41.Google Scholar
8. Peng, DT, Zhu, R, Yuan, XR, Zhang, X. Clinical study of deep brain magnetic stimulation technique in the treatment of Alzheimer’s disease [in Chinese]. Chin J Geriatr. 2012; 31(11): 929–931.Google Scholar
9. Zhang, Y, Mao, RR, Chen, ZF, et al. Deep-brain magnetic stimulation promotes adult hippocampal neurogenesis and alleviates stress-related behaviors in mouse models for neuropsychiatric disorders. Mol Brain. 2014; 7: 11.Google Scholar
10. Garcia-Toro, M, Montes, JM, Talavera, JA. Functional cerebral asymmetry in affective disorders: new facts contributed by transcranial magnetic stimulation. J Affect Disord. 2001; 66(2–3): 103–109.Google Scholar
11. Burt, T, Lisanby, SH, Sackeim, HA. Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. Int J Neuropsychopharmacol. 2002; 5(01): 73–103.Google Scholar
12. Gershon, AA, Dannon, PN, Grunhaus, L. Transcranial magnetic stimulation in the treatment of depression. Am J Psychiatry. 2003; 160(5): 835–845.Google Scholar
13. Thut, G, Veniero, D, Romei, V, Miniussi, C, Schyns, P, Gross, J. Rhythmic TMS causes local entrainment of natural oscillatory signatures. Curr Biol. 2011; 21(14): 1176–1185.Google Scholar
14. Veniero, D, Brignani, D, Thut, G, Miniussi, C. Alpha-generation as basic response-signature to transcranial magnetic stimulation (TMS) targeting the human resting motor cortex: a TMS/EEG co-registration study. Psychophysiology. 2011; 48(10): 1381–1389.Google Scholar
15. Sadaghiani, S, Scheeringa, R, Lehongre, K, Morillon, B, Giraud, AL, Kleinschmidt, A. Intrinsic connectivity networks, alpha oscillations, and tonic alertness: a simultaneous electroencephalography/functional magnetic resonance imaging study. J Neurosci. 2010; 30(30): 10243–10250.Google Scholar
16. Xiao, L, Feng, Y, Feng, L, Hu, C, Zhang, G, Wang, G. Effects of deep-brain magnetic stimulation on brain derived neurotrophic factor in treatment-resistant depression [in Chinese]. J Clin Psychiatry. 2015; 25(6): 361–364.Google Scholar
17. Jin, Y, Phillips, B. A pilot study of the use of EEG-based synchronized transcranial magnetic stimulation (sTMS) for treatment of major depression. BMC Psychiatry. 2014; 14: 13.Google Scholar
18. Park, H, Poo, M. Neurotrophin regulation of neural circuit development and function. Nat Rev Neurosci. 2013; 14(1): 7–23.Google Scholar
19. Groves, JO. Is it time to reassess the BDNF hypothesis of depression? Mol Psychiatry. 2007; 12(12): 1079–1088.Google Scholar
20. Adachi, M, Barrot, M, Autry, AE, Theobald, D, Monteggia, LM. Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy. Biol Psychiatry. 2008; 63(7): 642–649.Google Scholar
21. Duman, RS, Monteggia, LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry. 2006; 59(12): 1116–1127.Google Scholar
22. Brunoni, AR, Lopes, M, Fregni, F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol. 2008; 11(8): 1169.Google Scholar
23. Sen, S, Duman, R, Sanacora, G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry. 2008; 64(6): 527–532.Google Scholar
24. Hamilton, M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960; 23: 56–62.Google Scholar
25. Xie, GR, Shen, QJ. Use of the Chinese version of the Hamilton Rating Scale for Depression in general population and patients with major depression. Chin J Nerv Ment Dis. 1984; 10: 364.Google Scholar
26. Hamilton, M. The assessment of anxiety states by rating. Br J Psychiatry. 1959; 32(1): 50–55.Google Scholar
27. Guy, W. Clinical global impressions. In. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: National Institute for Mental Health; 1976: 218–222.Google Scholar
28. Trivedi, MH, Rush, AJ, Wisniewski, SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006; 163(1): 28–40.Google Scholar
29. Greenhouse, SW, Geisser, S. On methods in the analysis of profile data. Psychometrika. 1959; 24(2): 95–112.Google Scholar
30. Citrome, L. Number needed to treat: what it is and what it isn’t, and why every clinician should know how to calculate it. J Clin Psychiatry. 2011; 72(3): 412–413.Google Scholar
31. Cohen, J. Statistical Power Analysis for the Behavioral Sciences, 2nd ed. Hillsdale, NJ: Erlbaum; 1988.Google Scholar
32. Pan, W, Banks, WA, Fasold, MB, Bluth, J, Kastin, AJ. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology. 1998; 37(12): 1553–1561.Google Scholar
33. Sartorius, A, Hellweg, R, Litzke, J, et al. Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats. Pharmacopsychiatry. 2009; 42(6): 270–276.Google Scholar
34. Wang, HY, Crupi, D, Liu, J, et al. Repetitive transcranial magnetic stimulation enhances BDNF–TrkB signaling in both brain and lymphocyte. J Neurosci. 2011; 31(30): 11044–11054.Google Scholar
35. Yukimasa, T, Yoshimura, R, Tamagawa, A, et al. High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors. Pharmacopsychiatry. 2006; 39(2): 52–59.Google Scholar
36. Zanardini, R, Gazzoli, A, Ventriglia, M, et al. Effect of repetitive transcranial magnetic stimulation on serum brain-derived neurotrophic factor in drug resistant depressed patients. J Affect Disord. 2006; 91(1): 83–86.Google Scholar
37. Lang, C, Schüler, D. Biogenic nanoparticles: production, characterization, and application of bacterial magnetosomes. J Phys Condens Matter. 2006; 18(38): S2815–S2828.Google Scholar
38. Gedge, L, Beaudoin, A, Lazowski, L, du Toit, R, Jokic, R, Milev, R. Effects of electroconvulsive therapy and repetitive transcranial magnetic stimulation on serum brain-derived neurotrophic factor levels in patients with depression. Front Psychiatry. 2012; 3: 12.Google Scholar
39. Angelucci, F, Oliviero, A, Pilato, F, et al. Transcranial magnetic stimulation and BDNF plasma levels in amyotrophic lateral sclerosis. Neuroreport. 2004; 15(4): 717–720.Google Scholar
40. Rusovan, A, Kanje, M, Mild, KH. The stimulatory effect of magnetic fields on regeneration of the rat sciatic nerve is frequency dependent. Exp Neurol. 1992; 117(1): 81–84.Google Scholar
41. Volkow, ND, Tomasi, D, Wang, GJ, et al. Effects of low-field magnetic stimulation on brain glucose metabolism. NeuroImage. 2010; 51(2): 623–628.Google Scholar
42. Rokni-Yazdi, H, Sotoudeh, H, Akhondzadeh, S, Sotoudeh, E, Asadi, H, Shakiba, M. Antidepressant-like effect of magnetic resonance imaging-based stimulation in mice. Prog Neuropsychopharmacol Biol Psychiatry. 2007; 31(2): 503–509.Google Scholar
43. Drevets, WC, Price, JL, Furey, ML. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct. 2008; 213(1–2): 93–118.Google Scholar
44. Leuchter, AF, Cook, IA, Hunter, AM, Cai, C, Horvath, S. Resting-state quantitative electroencephalography reveals increased neurophysiologic connectivity in depression. PLoS One. 2012; 7(2): e32508.Google Scholar